B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ITPKC

MOLECULAR TARGET

inositol-trisphosphate 3-kinase C

UniProt: Q96DU7NCBI Gene: 802712 compounds

ITPKC (inositol-trisphosphate 3-kinase C) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ITPKC

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Genistein0.691
2kenpaullone0.691

About ITPKC as a Drug Target

ITPKC (inositol-trisphosphate 3-kinase C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ITPKC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ITPKC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.